Fusion Protein for the Treatment of Cancer and Autoimmune Diseases
KAHR Medical has raised €30M across 3 funding rounds from 4 investors, most recently a Series D+ round in Feb 2020. Based in Jerusalem, Israel; founded 2005; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-02-25 | Series D+ | €17M | Flerie Invest | View deal → |
| 2015-12-01 | Growth/Late | €11M | DSC Investment,Korea Investment Partners,Mirae Asset Venture Investment | View deal → |
| 2013-09-01 | Seed | €1.8M | — | View deal → |
